COVID-19 Pandemic Pivot Shows the Benefits of Microarray Technology
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Chris Wolski | Jan 9, 2023 | Molecular Diagnostic Analyzers |
PathogenDx’s involvement with Operation Warp Speed, demonstrated the efficacy of microarray technology for diagnostic testing.
Read MorePosted by Chris Wolski | Jan 5, 2023 | Middleware & Software |
These findings give labs a blueprint for using data analytics to ensure patient access to testing during future infectious disease outbreaks.
Read MorePosted by Chris Wolski | Jan 5, 2023 | Cervical (HPV) |
The triage approach offers women and labs a more efficient and effective way to diagnose and manage cervical cancer earlier.
Read MorePosted by Andy Lundin | Jan 4, 2023 | Covid 19, Swabs |
Researchers discovered that testing for the presence of a single immune system molecule on nasal swabs can help detect stealthy viruses.
Read MorePosted by Chris Wolski | Jan 4, 2023 | Emerging & Zoonotic Diseases, Immunoassay Reagents & test Kits |
Clinical labs learned about the limitations of mpox testing during last summer’s outbreak, taking away valuable lessons.
Read More